Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])
Recruiting
- Conditions
- Congenital Adrenal Hyperplasia
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Adrenas Therapeutics Inc
- Target Recruit Count
- 300
- Registration Number
- NCT05101902
- Locations
- 🇺🇸
Science37, Los Angeles, California, United States
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
Phase 1
Recruiting
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- Biological: AAV BBP-631
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Adrenas Therapeutics Inc
- Target Recruit Count
- 25
- Registration Number
- NCT04783181
- Locations
- 🇺🇸
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
News
No news found